Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.460
-0.080 (-2.26%)
At close: Mar 6, 2026, 4:00 PM EST
3.451
-0.010 (-0.27%)
After-hours: Mar 6, 2026, 7:56 PM EST
Recursion Pharmaceuticals Employees
Recursion Pharmaceuticals had 800 employees as of December 31, 2024. The number of employees increased by 300 or 60.00% compared to the previous year.
Employees
800
Change (1Y)
300
Growth (1Y)
60.00%
Revenue / Employee
$93,351
Profits / Employee
-$805,949
Market Cap
1.83B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Syndax Pharmaceuticals | 298 |
| Zymeworks | 264 |
| Relay Therapeutics | 192 |
| Aurinia Pharmaceuticals | 128 |
| Definium Therapeutics | 106 |
| Enliven Therapeutics | 65 |
| Tyra Biosciences | 60 |
RXRX News
- 1 day ago - Recursion Pharmaceuticals, Inc. (RXRX) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 10 days ago - Recursion Pharmaceuticals, Inc. (RXRX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 12 days ago - Recursion To Be Featured in HighRes' Lightning Talk at NVIDIA GTC - GlobeNewsWire
- 12 days ago - Recursion to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 17 days ago - Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25 - GlobeNewsWire
- 17 days ago - Applied Digital, Recursion Pharmaceuticals Stocks Drop. Blame Nvidia. - Barrons
- 6 weeks ago - Recursion Pharmaceuticals, Inc. (RXRX) Presents at 28th Annual Needham Growth Conference Transcript - Seeking Alpha